Matt has been in the pharmaceutical industry for over twenty years. Throughout his career Matt has orchestrated licensed agreements with Amneal, UCB, Hill Dermaceuticals and Symbiotec among others. Matt has also opened and expanded successful relationships with some of the largest and most prestigious US customers such as Walgreens, McKesson, and Econdisc. He graduated from Seton Hall University (BS) in 1986.

John joined the Company in September 2014. From 1998 to 2013 he was Executive Vice President – Finance and Chief Financial Officer of Westcon Group. Westcon Group is a global distributor of information technology communication equipment with sales in excess of $5 billion annually. From 1992 to 1997, Mr. O’Malley was Executive Vice President – Finance and Chief Financial Officer of Medical Resources, Inc. and its predecessor, NMR of America, Inc. These companies engaged in the operation of medical diagnostic imaging cetners throughout the US. From August 1984 to May 1992, Mr. O’Malley was employed by the public accounting firm of Ernst & Young LLP. Mr. O’Malley is a certified public accountant with a BS in accounting from the University of Delaware.

Chris started with Granard Pharmaceuticals in 1999 and currently drives all business development and strategic alliance initiatives on a global scale for Seton, Royal and Granard. Chris works within all aspects of product acquisition, licensing and development.

David brings twenty years of pharmaceutical experience in generic and brand sales, wholesale supply chain and sourcing, institutional and retail national account management and business development. David’s previous company experience includes Abbot Labs, AstraZeneca, AmericourceBergen, Teva and Breckenridge.